Transcriptomic signatures of alterations in a myoblast cell line infected with four distinct strains of Trypanosoma cruzi.

We examined the extent to which different Trypanosoma cruzi strains induce transcriptomic changes in cultured L(6)E(9) myoblasts 72 hours after infection with Brazil (TC I), Y (TC II), CL (TC II), and Tulahuen (TC II) strains. Expression of 6,289 distinct, fully annotated unigenes was quantified with 27,000 rat oligonucleotide arrays in each of the four replicas of all control and infected RNA samples. Considering changes greater than 1.5-fold and P values < 0.05, the Tulahuen strain was the most disruptive to host transcriptome (17% significantly altered genes), whereas the Y strain altered only 6% of the genes. The significantly altered genes in the infected cells were largely different among the strains, and only 21 genes were similarly changed by all four strains. However, myoblasts infected with different strains showed proportional overall gene-expression alterations. These results indicate that infection with different parasite strains modulates similar but not identical pathways in the host cells.

[1]  M. Pereira,et al.  Trypanosoma cruzi alters adherens junctions in cardiomyocytes. , 2008, Microbes and infection.

[2]  D. Spray,et al.  Alterations in myocardial gene expression associated with experimental Trypanosoma cruzi infection. , 2008, Genomics.

[3]  D. Spray,et al.  Trypanosoma cruzi induces changes in cardiac connexin43 expression. , 2008, Microbes and infection.

[4]  T. Shigihara,et al.  Transcriptome profile of Trypanosoma cruzi-infected cells: simultaneous up- and down-regulation of proliferation inhibitors and promoters , 2008, Parasitology Research.

[5]  M. Rossi,et al.  Reduction of gap and adherens junction proteins and intercalated disc structural remodeling in the hearts of mice submitted to severe cecal ligation and puncture sepsis* , 2007, Critical care medicine.

[6]  D. Spray,et al.  Pathology of mechanical and gap junctional co-coupling at the intercalated disc: Is sepsis a junctionopathy? , 2007, Critical care medicine.

[7]  J. Saffitz,et al.  Remodeling of Gap Junctions in Ischemic and Nonischemic Forms of Heart Disease , 2007, Journal of Membrane Biology.

[8]  W. Souza.  Chagas' disease: facts and reality. , 2007 .

[9]  J. A. López,et al.  Trypanosoma cruzi strains, Tulahuen 2 and Y, besides the difference in resistance to oxidative stress, display differential glucose-6-phosphate and 6-phosphogluconate dehydrogenases activities. , 2007, Acta tropica.

[10]  Wanderley de Souza.  Chagas' disease: facts and reality. , 2007, Microbes and infection.

[11]  D. Spray,et al.  Transcriptomic changes in developing kidney exposed to chronic hypoxia. , 2006, Biochemical and biophysical research communications.

[12]  H. Koga,et al.  Microarray Analysis of Host Gene‐Expression during Intracellular Nests Formation of Trypanosoma cruzi Amastigotes , 2005, Microbiology and immunology.

[13]  M. Lisanti,et al.  The Adipocyte as an Important Target Cell for Trypanosoma cruzi Infection* , 2005, Journal of Biological Chemistry.

[14]  Wei Li,et al.  Genes controlling multiple functional pathways are transcriptionally regulated in connexin43 null mouse heart. , 2005, Physiological genomics.

[15]  E. Oldfield,et al.  Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi. , 2004, International journal of antimicrobial agents.

[16]  Martin Metzger,et al.  Pathophysiology of the heart in Chagas' disease: current status and new developments. , 2003, Cardiovascular research.

[17]  D. Spray,et al.  Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy , 2003, Parasitology Research.

[18]  V. Popov,et al.  Profiling gene transcription reveals a deficiency of mitochondrial oxidative phosphorylation in Trypanosoma cruzi-infected murine hearts: implications in chagasic myocarditis development. , 2003, Biochimica et biophysica acta.

[19]  C. Carneiro,et al.  Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains. , 2001, Memorias do Instituto Oswaldo Cruz.

[20]  E. Cupolillo,et al.  A mini-exon multiplex polymerase chain reaction to distinguish the major groups of Trypanosoma cruzi and T. rangeli in the Brazilian Amazon. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[21]  S. G. Andrade.  Trypanosoma cruzi: clonal structure of parasite strains and the importance of principal clones. , 1999, Memorias do Instituto Oswaldo Cruz.

[22]  S. G. Andrade,et al.  Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology. , 1997, Revista da Sociedade Brasileira de Medicina Tropical.

[23]  A. Romanha,et al.  Biological characterization of Trypanosoma cruzi strains from different zymodemes and schizodemes. , 1991, Memorias do Instituto Oswaldo Cruz.

[24]  M. Olivares,et al.  Biological characterization of Trypanosoma cruzi zymodemes: in vitro differentiation of epimastigotes and infectivity of culture metacyclic trypomastigotes to mice. , 1990, Experimental parasitology.

[25]  R. Isturiz,et al.  Chagas Disease , 2021, Neglected Tropical Diseases.

[26]  B. Nadal-Ginard,et al.  Inhibition of muscle differentiation by trypanosoma cruzi. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Miles,et al.  DO RADICALLY DISSIMILAR TRYPANOSOMA CRUZI STRAINS (ZYMODEMES) CAUSE VENEZUELAN AND BRAZILIAN FORMS OF CHAGAS' DISEASE? , 1981, The Lancet.

[28]  Z. Brener,et al.  Infection of tissue culture cells with bloodstream trypomastigotes of Trypanosoma cruzi. , 1980, The Journal of parasitology.